|
|
||||||||
AJP - Gastrointestinal and Liver Physiology, Vol 268, Issue 4 673-G684, Copyright © 1995 by American Physiological Society
ARTICLES |
C. M. Hogaboam, K. Jacobson, S. M. Collins and M. G. Blennerhassett
Intestinal Disease Research Programme, McMaster University, Hamilton, Ontario, Canada.
We investigated the involvement of nitric oxide in trinitrobenzene-sulfonic acid (TNB) colitis. Every 24 h after TNB, rats were orally dosed with NG-nitro-L-arginine methyl ester (L-NAME; 30 mg/kg), NG-nitro-D-arginine methyl ester (D-NAME), or water, and food intake, body weight, and plasma nitrite levels were measured. On day 6, colonic nitric oxide synthase and myeloperoxidase (MPO) activity, histology, intestinal muscle growth, NADPH-diaphorase, and myenteric nerve function were assessed. Food intake and body weight were reduced during the first 72 h of colitis. On day 6 post-TNB, a fourfold increase in mucosal nitric oxide synthase, a 30-fold increase in MPO, and a fivefold elevation in plasma nitrite were measured. Smooth muscle hyperplasia and hypertrophy in both colonic muscle layers, numerous diaphorase-positive macrophages in the myenteric plexus, and a suppression of myenteric nerve function were also observed. Unlike D-NAME, oral L-NAME reduced MPO and intestinal muscle hyperplasia by > 90%. Likewise, plasma nitrite and colonic nitric oxide synthase were reduced by > 70%. L-NAME completely prevented macrophage infiltration into the muscle. Conversely, it had no effect on anorexia or intestinal smooth muscle hypertrophy, nor did it affect suppressed myenteric nerve neurotransmitter release. These results demonstrate the selective transmural protective effects of L-NAME in the inflamed colon, implicating nitric oxide as a mediator.
This article has been cited by other articles:
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Attalah, S. Honore, S. Eddahibi, E. Marcos, C.-J. Soussy, S. Adnot, and C. Delclaux Decreased exhaled nitric oxide as a marker of postinsult immune paralysis J Appl Physiol, October 1, 2004; 97(4): 1188 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Vallance, G. Dijkstra, B. Qiu, L. A. van der Waaij, H. van Goor, P. L. M. Jansen, H. Mashimo, and S. M. Collins Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G865 - G874. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Rodriguez-Cabezas, J. Galvez, M. D. Lorente, A. Concha, D. Camuesco, S. Azzouz, A. Osuna, L. Redondo, and A. Zarzuelo Dietary Fiber Down-Regulates Colonic Tumor Necrosis Factor {alpha} and Nitric Oxide Production in Trinitrobenzenesulfonic Acid-Induced Colitic Rats J. Nutr., November 1, 2002; 132(11): 3263 - 3271. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lourenssen, A. Jeromin, J. Roder, and M. G. Blennerhassett Intestinal inflammation modulates expression of the synaptic vesicle protein neuronal calcium sensor-1 Am J Physiol Gastrointest Liver Physiol, June 1, 2002; 282(6): G1097 - G1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
S J H van Deventer Small therapeutic molecules for the treatment of inflammatory bowel disease Gut, May 1, 2002; 50(90003): iii47 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wallace and L. Ma Inflammatory Mediators in Gastrointestinal Defense and Injury Experimental Biology and Medicine, December 1, 2001; 226(11): 1003 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Krieglstein, W. H. Cerwinka, F. S. Laroux, J. W. Salter, J. M. Russell, G. Schuermann, M. B. Grisham, C. R. Ross, and D. N. Granger Regulation of Murine Intestinal Inflammation by Reactive Metabolites of Oxygen and Nitrogen: Divergent Roles of Superoxide and Nitric Oxide J. Exp. Med., October 29, 2001; 194(9): 1207 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Paul-Clark, D. W. Gilroy, D. Willis, D. A. Willoughby, and A. Tomlinson Nitric Oxide Synthase Inhibitors Have Opposite Effects on Acute Inflammation Depending on Their Route of Administration J. Immunol., January 15, 2001; 166(2): 1169 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Ajuebor, C. M. Hogaboam, S. L. Kunkel, A. E. I. Proudfoot, and J. L. Wallace The Chemokine RANTES Is a Crucial Mediator of the Progression from Acute to Chronic Colitis in the Rat J. Immunol., January 1, 2001; 166(1): 552 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Blennerhassett and S. Lourenssen Neural regulation of intestinal smooth muscle growth in vitro Am J Physiol Gastrointest Liver Physiol, September 1, 2000; 279(3): G511 - G519. [Abstract] [Full Text] [PDF] |
||||
![]() |
P KUBES Inducible nitric oxide synthase: a little bit of good in all of us Gut, July 1, 2000; 47(1): 6 - 9. [Full Text] [PDF] |
||||
![]() |
D.-M. McCafferty, E. Sihota, M. Muscara, J. L. Wallace, K. A. Sharkey, and P. Kubes Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice Am J Physiol Gastrointest Liver Physiol, July 1, 2000; 279(1): G90 - G99. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M McCAFFERTY Peroxynitrite and inflammatory bowel disease Gut, March 1, 2000; 46(3): 436 - 439. [Full Text] [PDF] |
||||
![]() |
D-M McCafferty, M Miampamba, E Sihota, K A Sharkey, and P Kubes Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice Gut, December 1, 1999; 45(6): 864 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sanovic, D. P. Lamb, and M. G. Blennerhassett Damage to the Enteric Nervous System in Experimental Colitis Am. J. Pathol., October 1, 1999; 155(4): 1051 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kawachi, A. Cockrell, F. S. Laroux, L. Gray, D. N. Granger, H. C. van der Heyde, and M. B. Grisham Role of inducible nitric oxide synthase in the regulation of VCAM-1 expression in gut inflammation Am J Physiol Gastrointest Liver Physiol, September 1, 1999; 277(3): G572 - G576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Million, Y. Tache, and P. Anton Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: protective role of brain CRF Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G1027 - G1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Binion, S. Fu, K. S. Ramanujam, Y. C. Chai, R. A. Dweik, J. A. Drazba, J. G. Wade, N. P. Ziats, S. C. Erzurum, and K. T. Wilson iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion Am J Physiol Gastrointest Liver Physiol, September 1, 1998; 275(3): G592 - G603. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wallace, W. McKnight, S. Asfaha, and D. Y. Liu Reduction of acute and reactivated colitis in rats by an inhibitor of neutrophil activation Am J Physiol Gastrointest Liver Physiol, May 1, 1998; 274(5): G802 - G808. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aiko, J. Fuseler, and M. B. Grisham Effects of Nitric Oxide Synthase Inhibition or Sulfasalazine on the Spontaneous Colitis Observed in HLA-B27 Transgenic Rats J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 722 - 727. [Abstract] [Full Text] |
||||
![]() |
T D WARNER and S A McCARTNEY NOS inhibitors in colitis: a suitable case for treatment? Gut, February 1, 1998; 42(2): 152 - 153. [Full Text] [PDF] |
||||
![]() |
H Kimura, R Hokari, S Miura, T Shigematsu, M Hirokawa, Y Akiba, I Kurose, H Higuchi, H Fujimori, Y Tsuzuki, et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis Gut, February 1, 1998; 42(2): 180 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Kuemmerle Synergistic regulation of NOS II expression by IL-1beta and TNF-alpha in cultured rat colonic smooth muscle cells Am J Physiol Gastrointest Liver Physiol, January 1, 1998; 274(1): G178 - G185. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Janoff, H. Hayakawa, D. N. Taylor, C. E. Fasching, J. R. Kenner, E. Jaimes, and L. Raij Nitric oxide production during Vibrio cholerae infection Am J Physiol Gastrointest Liver Physiol, November 1, 1997; 273(5): G1160 - G1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Conner, S. Brand, J. M. Davis, F. S. Laroux, V. J. Palombella, J. W. Fuseler, D. Y. Kang, R. E. Wolf, and M. B. Grisham Proteasome Inhibition Attenuates Nitric Oxide Synthase Expression, VCAM-1 Transcription and the Development of Chronic Colitis J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1615 - 1622. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |